Clarithromycin EP impurity F
| Product Name | Clarithromycin EP impurity F |
|---|---|
| Alternate Names | Clarithromycin Impurities, Impurities of Clarithromycin |
| CAT No. | CS-T-57950 |
| CAS No. | 128940-83-0 |
| Category | Impurities |
| Stock | IN-Stock |
| Mol. Wt. | 761.98 g/mol |
| Mol. For. | C₃₉H₇₁NO₁₃ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Clarithromycin |
| Purity | 95% |
| Therapeutic | Anti-Cancer / Oncology |
| Smileys | C[C@@H]([C@@H]([C@H](C(O[C@@H]1CC)=O)C)O[C@@](O[C@@H](C)[C@@H]2O)([H])C[C@@]2(C)OC)[C@H]([C@@](C)(C[C@H](C([C@@H]([C@@H](O)[C@]1(C)OC)C)=O)C)OC)O[C@@](O[C@H](C)C[C@@H]3N(C)C)([H])[C@@H]3O |
| Canonical Smiles | CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)N(C)C)O)(C)OC)C)C)O)(C)OC |
| InchIKey | ZABLXHVYLJLDOX-HIKKGGSBSA-N |
| Inchl | InChI=1S/C39H71NO13/c1-16-27-39(10,48-15)32(43)22(4)29(41)20(2)18-38(9,47-14)34(53-36-30(42)26(40(11)12)17-21(3)49-36)23(5)31(24(6)35(45)51-27)52-28-19-37(8,46-13)33(44)25(7)50-28/h20-28,30-34,36,42-44H,16-19H2,1-15H3/t20-,21-,22+,23+,24-,25+,26+,27-,28+,30-,31+,32-,33+,34-,36+,37-,38-,39-/m1/s1 |
| IUPAC | (3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-6-[(2S,3R,4S,6R)-4-(dimethylamino)-3-hydroxy-6-methyloxan-2-yl]oxy-14-ethyl-12-hydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-7,13-dimethoxy-3,5,7,9,11,13-hexamethyl-oxacyclotetradecane-2,10-dione |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Clarithromycin EP impurity F, also known as 1'-N-Desmethyl Clarithromycin, is a chemical compound that is commonly used in the pharmaceutical industry as a reference standard for quality control purposes. It is a structural impurity of Clarithromycin, a macrolide antibiotic that is used to treat a wide range of bacterial infections. The presence of Clarithromycin EP impurity F in Clarithromycin samples can affect the purity and potency of the drug, and can also lead to adverse effects in patients.
The chemical formula of Clarithromycin EP impurity F is C38H68N2O13, and its molecular weight is 760.95 g/mol. It is a white to off-white crystalline powder, and its melting point ranges from 168°C to 170°C. Clarithromycin EP impurity F is soluble in methanol, ethanol, and acetone, but is insoluble in water.
In terms of its usage, Clarithromycin EP impurity F is primarily used as a reference standard in the quality control of Clarithromycin drugs. It is also used in the development and validation of analytical methods for the detection and quantification of Clarithromycin impurities. The presence of Clarithromycin EP impurity F in Clarithromycin samples can affect the purity and potency of the drug, and can also lead to adverse effects in patients. Therefore, it is important to accurately detect and quantify this impurity to ensure the safety and efficacy of Clarithromycin drugs.
Get an Instant Quote
Related Compounds
Clarithromycin-N-methyl-13C-D3 | Clarithromycin EP impurity C | Clarithromycin 9-Oxime | Clarithromycin EP impurity O | Clarithromycin EP impurity D | Clarithromycin EP impurity G | Clarithromycin EP impurity L | Clarithromycin_EDO | Clarithromycin_EO | Clarithromycin 2’-O-Acetate | Clarithromycin EP impurity I | Clarithromycin EP impurity B | Clarithromycin_MEDO | Clarithromycin EP impurity M | Clarithromycin EP impurity A | Clarithromycin EP impurity P | Clarithromycin Impurity 4 | Clarithromycin Corresponding impurity of erythromycin E | Clarithromycin EP impurity K | Clarithromycin EP impurity N | Clarithromycin EP impurity H | Clarithromycin EP impurity E | Clarithromycin EP impurity J | N-Nitroso-N-Desmethyl-Clarithromycin |